SOCS2 and in situ carcinoma: Intense investigation into the immune potentiating mechanisms of SOCS2 and CIS may reveal important clues about immune regulatory mechanisms and provide useful new approaches for immune-driven diseases from autoimmune diseases to cancer immunotherapies.